Expression of concern
Novel fatty chain-modified GLP-1R G-protein biased agonist exerts prolonged anti-diabetic effects through targeting receptor binding sites
Paper Information
Record ID:
43553
Author(s):
Journal:
Publication Date:
February 24, 2020
Retraction Date:
November 15, 2022
(3.0 years years ago)
Subjects:
Broad Categories:
Biology
Biology
Institutions:
- Department of Endocrinology, West China Hospital, Sichuan University Chengdu 610041 Sichuan China
- Department of Endocrinology, Affiliated Hospital of Hubei University for Nationalities Enshi 445000 Hubei China
- China Pharmaceutical University Nanjing Jiangsu P. R. China
- Jiangnan University Wuxi Jiangsu P. R. China
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Royal Society of Chemistry (RSC)
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Expression of concern Details
Retraction Reasons:
Nature of Retraction:
Expression of concern
Retraction Notice:
10.1039/d2ra90118hCitations (10)
10
Total Citations2
Post-Retraction(20.0%)
7
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
2
Within 1 year
0
After 2+ years
321
Days since retraction (latest)
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
Head-to-head comparison of BAM15, semaglutide, rosiglitazone, NEN, and calorie restriction on metabolic physiology in female db/db mice
Sing-Young Chen, Martina Beretta, Ellen M. Olzomer et al. (15 authors)
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Open Access
Published: Oct 2023
3 citations
3 citations
321 days after retraction
GLP-1R Signaling and Functional Molecules in Incretin Therapy
Wenwei Wan, Qikai Qin, Linshan Xie et al. (7 authors)
Molecules
Open Access
Published: Jan 2023
25 citations
25 citations
57 days after retraction
A Review of Current Trends with Type 2 Diabetes Epidemiology, Aetiology, Pathogenesis, Treatments and Future Perspectives
Josh Reed, Stephen C. Bain, Venkateswarlu Kanamarlapudi
Diabetes Metabolic Syndrome and Obesity
Open Access
Published: Aug 2021
307 citations
307 citations
471 days before retraction
Evaluation of efficacy- versus affinity-driven agonism with biased GLP-1R ligands P5 and exendin-F1
Amaara Marzook, Shiqian Chen, Philip Pickford et al. (14 authors)
Biochemical Pharmacology
Open Access
Published: Jun 2021
10 citations
10 citations
521 days before retraction
The Interplay of Glucagon-Like Peptide-1 Receptor Trafficking and Signalling in Pancreatic Beta Cells
Amaara Marzook, Alejandra Tomás, Ben Jones
Frontiers in Endocrinology
Open Access
Published: May 2021
78 citations
78 citations
554 days before retraction
The therapeutic potential of GLP‐1 receptor biased agonism
Ben Jones
British Journal of Pharmacology
Open Access
Published: Apr 2021
64 citations
64 citations
573 days before retraction
Evaluation of efficacy- <i>versus</i> affinity-driven agonism with biased GLP-1R ligands P5 and exendin-F1
Amaara Marzook, Shiqian Chen, Philip Pickford et al. (14 authors)
bioRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Apr 2021
592 days before retraction
The impact of chemical engineering and technological advances on managing diabetes: present and future concepts
Sabine Szunerits, Sorin Melinte, Alexandre Barras et al. (7 authors)
Chemical Society Reviews
Published: Dec 2020
39 citations
39 citations
698 days before retraction
Ligand-Specific Factors Influencing GLP-1 Receptor Post-Endocytic Trafficking and Degradation in Pancreatic Beta Cells
Zijian Fang, Shiqian Chen, Yusman Manchanda et al. (18 authors)
International Journal of Molecular Sciences
Open Access
Published: Nov 2020
42 citations
42 citations
736 days before retraction
Related Records
This article has multiple records in the database due to different notices:
Record #50712
Jan 04, 2024Quick Stats
Total Citations:
19
Years Since Retraction:
3.0 years
Open Access:
Yes
Last Checked:
Jul 24, 2025